JWM
ABBV icon

Jackson Wealth Management’s AbbVie ABBV Stock Holding History

Jackson Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
4,109
-41,606
-91% -$8.95M 0.61% 33
2026
Q1 		$9.94M Sell
45,715
-196
-0.4% -$43.5K 1.02% 26
2025
Q4 		$10.5M Buy
45,911
+1,532
+3% +$349K 1.02% 28
2025
Q3 		$10.3M Buy
44,379
+928
+2% +$189K 1.03% 26
2025
Q2 		$8.06M Sell
43,451
-227
-0.5% -$42.2K 0.88% 31
2025
Q1 		$9.15M Buy
43,678
+11,825
+37% +$2.3M 1.11% 19
2024
Q4 		$5.66M Buy
31,853
+3,344
+12% +$615K 0.64% 43
2024
Q3 		$5.63M Buy
+28,509
New +$5.32M 0.67% 42
2024
Q2 		– Sell
-1,146
Closed -$209K – 117
2024
Q1 		$209K Buy
+1,146
New +$198K 0.03% 139
2023
Q1 		– Sell
-31,396
Closed -$5.07M – 131
2022
Q4 		$5.07M Sell
31,396
-886
-3% -$136K 1.86% 15
2022
Q3 		$4.33M Buy
32,282
+19,837
+159% +$2.85M 0.85% 32
2022
Q2 		$1.91M Sell
12,445
-20,217
-62% -$3.09M 0.88% 31
2022
Q1 		$5.29M Buy
32,662
+31
+0.1% +$4.5K 0.74% 39
2021
Q4 		$4.42M Buy
32,631
+711
+2% +$84K 0.56% 51
2021
Q3 		$38K Sell
31,920
-2,507
-7% -$286K 0.46% 40
2021
Q2 		$3.88M Buy
34,427
+2,170
+7% +$244K 0.49% 52
2021
Q1 		$3.49M Buy
32,257
+1,408
+5% +$151K 0.52% 55
2020
Q4 		$3.31M Buy
30,849
+18,484
+149% +$1.78M 0.45% 57
2020
Q3 		$1.08M Buy
12,365
+1,729
+16% +$163K 0.16% 101
2020
Q2 		$1.04M Buy
+10,636
New +$936K 0.19% 97

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jackson Wealth Management's ABBV Position: Q2 2026 in Review

Jackson Wealth Management reduced its AbbVie (ABBV) stake by 91% in Q2 2026, selling an estimated $8.95M and leaving 4,109 shares worth $1.03M. The position accounts for 0.61% of the portfolio, ranked #33.

Jackson Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 20 quarters since. The position peaked at $10.5M in Q4 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jackson Wealth Management held 4,109 shares of AbbVie worth $1.03M as of Q2 2026.
  • Jackson Wealth Management sold 41,606 AbbVie shares in Q2 2026, an estimated $8.95M.
  • AbbVie made up 0.61% of Jackson Wealth Management's portfolio in Q2 2026, its #33 holding.
  • Jackson Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 20 quarters since.
  • Jackson Wealth Management's AbbVie position peaked at $10.5M in Q4 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jackson Wealth Management's 13F filing for Q2 2026, filed 20 Aug 2026.